BioPharm International
April 03, 2020
Upstream Processing
33
4
New bioreactor designs, coupled with better media, process intensification and analytics, continue to improve upstream bioprocessing.
April 02, 2020
Ask the Expert
33
4
Addressing data integrity, quality culture, aging facilities, investigations/corrective actions and preventive actions, and risk management is key when conducting audits, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
April 01, 2020
Cover Story: Upstream Processing
33
4
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
April 01, 2020
BioBusiness
33
4
As politicians focus on drug cost reduction, biopharmaceutical companies in the US are moving to states with lower taxes and relocating some facilities that had been offshore.
April 01, 2020
Downstream Processing
33
4
The latest advances in downstream technologies include a fluid chromatography system, sensing and control units for hygienic valves, a compact valve platform, a membrane purification column, and a protein A affinity chromatography resin.
April 01, 2020
Product Spotlight
33
4
General Purpose Pro Centrifuge Series centrifuges by Thermo Fisher Scientific are designed to deliver a regulatory-compliant benchtop separation solution to meet the application needs of scientists working in biopharmaceuticals, academic research, and clinical diagnostic applications.
April 01, 2020
Product Spotlight
33
4
Shim-pack Bio Diol and IEX columns from Shimadzu Scientific Instruments improve the accuracy of the characterization of peptides, oligonucleotides, and other biopharmaceuticals.
April 01, 2020
Outsourcing
33
4
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
April 01, 2020
Quality/Regulations
33
4
Demonstrating interchangeability can ensure biosimilar substitutability at the pharmacy level.
April 01, 2020
Analytics
33
4
A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies.
April 01, 2020
Operations
33
4
More sustainable and functional packaging protects temperature-sensitive drugs.
April 01, 2020
Regulatory Beat
33
4
FDA is encouraging alternative insulins and challenging anticompetitive practices.
April 01, 2020
Issue PDF
33
4
Click the title above to open the BioPharm International April 2020 issue in an interactive PDF format.
April 01, 2020
Manufacturing
33
4
Single-use solutions continue to grow in popularity, largely as a result of the cost and time efficiencies they can afford biopharma companies.
April 01, 2020
Operations
33
4
As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
April 01, 2020
Operations
33
4
Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain.
April 01, 2020
Operations
33
4
Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
April 01, 2020
From the Editor
33
4
As the coronavirus pandemic unfolds, the bio/pharma industry must practice science over hype.